Babaji posted what drD posted on YMB about Dr. Kel
Post# of 154853
(Total Views: 1190)
Posted On: 12/01/2021 8:45:31 PM
Babaji posted what drD posted on YMB about Dr. Kelly's presentation. I know one has to be careful about what to believe on the internet, but it does appear he really is a doctor who believes in Leronlimab and seems to be reliable. I am adding some more of his posts about Dr. Kelly's presentation which add to the previous post. Most of them are in response to other posters' questions, but the message he is conveying will be apparent. Really sounds like it went well.
He’s a great presenter and held the audience’s attention unlike the other presenters .
I spoke to a few of them afterwards and many were interested in the No side effects of LL as most other MABS do have serious adverse ones ..
Lots of interest also in the monotherapy treatment for HIV and the prep hiv indication which Dr Kelly stated could be once a month and perhaps later might to even every 3 months .
The results of the critical covid indication also drew much attention .
Dr Kelly did a great job explaining how the dosage in the new trial is 4 consecutive doses rather than the 2 that were utilized and how the results would reach a higher percentage of cure . They were definitely impressed!
No side effects and the rebooting of the immune system is a Winner! Yeah , they were awed ..
Yes it was great and Dr Kelly is an excellent speaker .
He won the day and many came up to him to congratulate him on an excellent presentation.
I think the point is that many scientists and doctors from all over the world were introduced to the amazing molecule Leronlimab . And they were impressed .
Another great point that Dr Kelly made yesterday and perked up the audience was about the crossing of the BBB and how it relates to many viral infections that cause neurological damage/changes and how it relates to the disappearance of brain Mets in the mTNBC patient trial that has already been submitted to the FDA . This one is Big .
The crossing of the BBB and the shrinkage/disappearance of the brain Mets in the mTNBC trial that was submitted to the FDA is what makes it impossible for the FDA not to grant BTD for Leronlimab as this is the exact definition of breakthrough medicine and technology designation .
It is my belief it will be granted sooner than the required 60 days which are now at about 36 remaining
So I am expecting it to be granted before the end of the year .
Dr Kelly mentioned the article for the peer reviewed journal being submitted yesterday at the conference. This is Big
He’s a great presenter and held the audience’s attention unlike the other presenters .
I spoke to a few of them afterwards and many were interested in the No side effects of LL as most other MABS do have serious adverse ones ..
Lots of interest also in the monotherapy treatment for HIV and the prep hiv indication which Dr Kelly stated could be once a month and perhaps later might to even every 3 months .
The results of the critical covid indication also drew much attention .
Dr Kelly did a great job explaining how the dosage in the new trial is 4 consecutive doses rather than the 2 that were utilized and how the results would reach a higher percentage of cure . They were definitely impressed!
No side effects and the rebooting of the immune system is a Winner! Yeah , they were awed ..
Yes it was great and Dr Kelly is an excellent speaker .
He won the day and many came up to him to congratulate him on an excellent presentation.
I think the point is that many scientists and doctors from all over the world were introduced to the amazing molecule Leronlimab . And they were impressed .
Another great point that Dr Kelly made yesterday and perked up the audience was about the crossing of the BBB and how it relates to many viral infections that cause neurological damage/changes and how it relates to the disappearance of brain Mets in the mTNBC patient trial that has already been submitted to the FDA . This one is Big .
The crossing of the BBB and the shrinkage/disappearance of the brain Mets in the mTNBC trial that was submitted to the FDA is what makes it impossible for the FDA not to grant BTD for Leronlimab as this is the exact definition of breakthrough medicine and technology designation .
It is my belief it will be granted sooner than the required 60 days which are now at about 36 remaining
So I am expecting it to be granted before the end of the year .
Dr Kelly mentioned the article for the peer reviewed journal being submitted yesterday at the conference. This is Big
(14)
(0)